Adult T-Cell Lymphoma/Leukemia
1 clinical trials · Condition
◉ Watch Adult T-Cell Lymphoma/Leukemia
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome (NCT04185220) | National Cancer Institute (NCI) | 2020-02-26 |
Track Adult T-Cell Lymphoma/Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.